Now, Thailand suspends AstraZeneca vaccine rollout
BANGKOK: Thailand on Friday joined several European nations in suspending the AstraZeneca vaccine over blood clot fear...
Thailand has delayed the rollout of the AstraZeneca's Covid-19 vaccine over reports of blood clots, despite there being no evidence of a link to the jab.The country's prime minister was due to kick off the country's vaccination drive by getting the vaccine on Friday. This has now been cancelled.The delay comes after a number of countries, including Denmark and Norway, suspended the use of the jab.Around 5 million Europeans have already received the AstraZeneca vaccine.Thailand's public health ministry said it made the decision because the country had not been "hard hit" by the virus and it had other vaccines it could rely on in the meantime.There have been about 30 cases in Europe of "thromboembolic events" - or developing blood clots - after the vaccine was administered.On Friday, Bulgaria became the latest country to suspend use of the vaccine, and it asked for a written statement from the European Medicines Agency (EMA) accounting for the jab's safety.The EMA said on Thursday that there was no indication the jab was causing the blood clots, adding that its "benefits continue to outweigh its risks".
View SourceThis notice has been removed
The content is no longer available
Thailand has delayed the rollout of the AstraZeneca's Covid-19 vaccine over reports of blood clots, despite there being no evidence of a link to the jab.The country's prime minister was due to kick off the country's vaccination drive by getting the vaccine on Friday. This has now been cancelled.The delay comes after a number of countries, including Denmark and Norway, suspended the use of the jab.Around 5 million Europeans have already received the AstraZeneca vaccine.Thailand's public health ministry said it made the decision because the country had not been "hard hit" by the virus and it had other vaccines it could rely on in the meantime.There have been about 30 cases in Europe of "thromboembolic events" - or developing blood clots - after the vaccine was administered.On Friday, Bulgaria became the latest country to suspend use of the vaccine, and it asked for a written statement from the European Medicines Agency (EMA) accounting for the jab's safety.The EMA said on Thursday that there was no indication the jab was causing the blood clots, adding that its "benefits continue to outweigh its risks".
No results found
Try a different search term
Something went wrong
No notices yet
No notices match these filters
Couldn't load notices
You're all caught up 🎉
Sign in to continue to Global Noticeboard
Enter your email to receive a reset link
Create a new password for your account
You are marking this Notice are inappropriate, and you belive it infringes on the Global Noticeboard Community Guidelines (link). Is this so?
Create 3 Noticeboards to earn this Silver level Community Champion Badge.
View all badges that you can earnPlease tell us why you are reporting this content.
Discussion (0)
No comments yet